南财智讯1月23日电，杰美特发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为亏损 4400.00万元—6400.00万元；预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为亏损 6700.00万元—9700.00万元，变动原因：1、受客户业务变动及国际政策影响，公司整体收入及毛利额减 少。2025年度，虽然公司自有品牌业务收入较上年同期有所增加，但公司ODM/OEM业务的国内部分客 户因自身业务变动，对公司的订单需求减少，叠加海外部分国家因关税政策变化及国际政治形势的影 响，部分境外客户转移供应链到东南亚地区，减少对公司的订单量，导致公司ODM/OEM业务收入同比 减少；因此公司整体业务收入较上年同期减少，受此影响，公司的毛利额亦同比减少。2、受货币市场 波动影响，财务费用增加。因公司外销业务主要以美元结算，受美元汇率波动影响，公司2025年汇兑损 失增加；受市场利率下行的影响，公司现金管理收益较上年同期亦有所下降。3、业务推广费较上年同 期增加。2025年度，公司销售费用较上年同期有所增加，主要是公司2025年加大了自有品牌业务的开拓 力度，业务推广费有所增加，但同步带动了自有 ...

Core Viewpoint - Jiuan Medical experienced a decline of 2.78% in stock price on November 11, with a trading volume of 1.483 billion yuan, indicating market volatility and investor sentiment towards the company [1]. Financing and Margin Trading - On November 11, Jiuan Medical had a financing buy-in amount of 198 million yuan and a financing repayment of 188 million yuan, resulting in a net financing purchase of 9.05 million yuan [1]. - The total margin trading balance for Jiuan Medical reached 1.242 billion yuan as of November 11, with a financing balance of 1.231 billion yuan, accounting for 6.16% of the circulating market value, which is above the 90th percentile of the past year [1]. - In terms of securities lending, Jiuan Medical repaid 4,600 shares and sold 300 shares on November 11, with a remaining short position of 261,100 shares and a short balance of 11.2173 million yuan, also above the 90th percentile of the past year [1]. Company Overview - Jiuan Medical, established on August 22, 1995, and listed on June 10, 2010, is located in Tianjin and specializes in the research, production, and sales of home medical health electronic products [1]. - The revenue composition of Jiuan Medical includes iHealth series products (78.56%), ODM/OEM products (7.72%), internet medical products and services (6.57%), new retail business (5.03%), traditional hardware products (1.46%), and others (0.66%) [1]. Shareholder and Financial Performance - As of October 31, the number of shareholders for Jiuan Medical was 67,500, a decrease of 3.30% from the previous period, while the average circulating shares per person increased by 3.41% to 6,878 shares [2]. - For the period from January to September 2025, Jiuan Medical reported a revenue of 1.069 billion yuan, a year-on-year decrease of 48.89%, while the net profit attributable to shareholders increased by 16.11% to 158.9 million yuan [2]. Dividend and Institutional Holdings - Jiuan Medical has distributed a total of 1.794 billion yuan in dividends since its A-share listing, with 1.39 billion yuan distributed over the past three years [3]. - As of September 30, 2025, among the top ten circulating shareholders, Huabao Zhongzheng Medical ETF held 9.4265 million shares, a decrease of 1.562 million shares from the previous period, while other institutional shareholders also reported reductions in their holdings [3].